Concepedia

Author

Ekaterina Mikhailova

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and ImmunologyORCID

Also Known As

E. Mikhailova, E. V. Mikhailova, Ekaterina Mikhailova

42

Publications

261

Citations

10

H-Index

19

Concepts

All Affiliations

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and ImmunologyRegional Children's Clinical Hospital No. 1Institute of Medical Cell TechnologiesRussian Children's Clinical HospitalNational Medical Research Center for Hematology
EM

About

Ekaterina Mikhailova is an author at Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology specializing in medicine, health sciences, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

30

2

Medicine

2

2

30

3

Immunology

2

2

30

4

Pathology

2

2

30

5

Blood Transplantation

1

1

13

Ekaterina Mikhailova

×

11

Publications

202

Citations

10

H-Index

YearCitations

Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease

Ekaterina Mikhailova, Alexandra Semchenkova, Olga Illarionova,

British Journal of Haematology

2021

39

Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy

Alexandra Semchenkova, Ekaterina Mikhailova, Alexander Komkov,

International Journal of Molecular Sciences

2022

34

Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab

Ekaterina Mikhailova, Evgeny V. Gluhanyuk, Olga Illarionova,

Haematologica

2020

21

Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies

Tatiana Verzhbitskaya, I. A. Demina, Ekaterina Mikhailova,

Pediatric Hematology/Oncology and Immunopathology

2023

17

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy

Ekaterina Mikhailova, Olga Illarionova, Alexander Komkov,

Cancers

2022

16

GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients

Agnesa Panferova, M. V. Gaskova, Eugenyi Nikitin,

International Journal of Laboratory Hematology

2021

14

B‐lineage antigens that are useful to substitute <scp>CD19</scp> for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after <scp>CD19</scp> targeting

Ekaterina Mikhailova, Albert Itov, Elena Zerkalenkova,

Cytometry Part B Clinical Cytometry

2022

14

The influence of a dosage regimen of dexamethasone on detection of normal B-cell precursors in the bone marrow of children with BCP-ALL at the end of induction therapy

Ekaterina Mikhailova, Tatiana Verzhbitskaya, Julia Roumiantseva,

Pediatric Hematology/Oncology and Immunopathology

2020

13

Chimerism evaluation in measurable residual disease‐suspected cells isolated by flow cell sorting as a reliable tool for measurable residual disease verification in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Alexandra Semchenkova, Vladimir Zhogov, Olga Illarionova,

Cytometry Part B Clinical Cytometry

2020

13

Blinatumomab following haematopoietic stem cell transplantation – a novel approach for the treatment of acute lymphoblastic leukaemia in infants

Veronika Fominikh, Ekaterina Mikhailova, Grigory Tsaur,

British Journal of Haematology

2021

11

Page 1